| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.3 | 0.3 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |